Format

Send to

Choose Destination
Curr Opin Pulm Med. 2011 Nov;17(6):467-72. doi: 10.1097/MCP.0b013e32834b8bdb.

Cystic fibrosis lung transplantation.

Author information

1
Division of Pulmonary and Critical Care Medicine, Johns Hopkins University, School of Medicine, Johns Hopkins Hospital, Baltimore, Maryland 21205, USA. abraun1@jhmi.edu

Abstract

PURPOSE OF REVIEW:

This review summarizes recently published investigations on issues pertaining to cystic fibrosis (CF) lung transplantation. We specifically focus on indications and candidate selection as well as infectious and noninfectious issues specific to CF lung transplant recipients.

RECENT FINDINGS:

Recent studies have focused on candidate adequacy in high-risk CF patients. We review the current literature on individuals who develop respiratory failure requiring mechanical ventilation and those patients with a pretransplant diagnosis of pulmonary hypertension. Furthermore, the management of peri-operative infectious issues is reviewed including recurrent infections with multidrug-resistant bacterial, mycobacterial, and fungal organisms. Other CF-specific issues addressed include common comorbidities such as CF-related diabetes, gastroesophageal reflux, CF liver disease, and bone metabolism.

SUMMARY:

Lung transplantation is a limited, but potentially life-saving therapeutic option for patients with CF. Optimal candidate selection and awareness of CF-specific issues in the pretransplant and posttransplant setting may lead to better long-term outcomes.

PMID:
21897255
DOI:
10.1097/MCP.0b013e32834b8bdb
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wolters Kluwer
Loading ...
Support Center